Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Tianjin, Tianjin Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT | Relapse Acute Myeloid Leukemia | Recruiting | Phase 2 | 2024-06-06 | NCT06447090 |